• Home
  • Samyang Biopharmaceuticals Corp
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
2D57
Book a meeting

Samyang Biopharmaceuticals Corp

About Samyang Biopharmaceuticals Corp

Samyang Biopharm is specialized in commercialization of first generics and drug delivery system (DDS)-based modified drugs for cancer tratment and development of small-molecule drugs, new biologic drugs, and cancer virus vaccines. 

Samyang Biopharm is exporting its oncology products to more than 25 countries and its cytotoxic manufacturing facility is authorized by authorities from Korea, Europe, and Japan. To expand its Contract Development & Manufacturing, Samyang Biopharm is constructing a new facility which is expected to achieve full cGMP operation and the construction will be completed in 2020. Furthermore, it continues to enhance its product portfolio to meet the latest ph...

Read more Show less
Certifications
  • CE
    CE
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2016
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Other
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Other
Pharmaceutical Company (generic finished products)
Contact info
  • +82 2 6000 1843
  • 295 Pangyo-ro, Bundang-gu, 13488, Seongnam-si, Korea, Republic Of
Show contact info Hide contact info

Products from Samyang Biopharmaceuticals Corp (6)

  • FPFs

    Product FPFs

    • Genexol®PM Inj.(Paclitaxel)   • Genexol® Inj.(Paclitaxel) • Nanoxel®M Inj.(Docetaxel) • Docetaxel Inj.(Docetaxel) • Nexatin® Inj.(Oxaliplatin) • Everose® Tab.(Everolimus) • Pemed®S Inj.(Pemetrexed) • Azalid® Inj.(Azacitidine) • Decilid® Inj.(Decitabine) • Lenalid® Inj.(Lenalid...
  • APIs

    Product APIs

    • Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request)
  • CDMO

    Product CDMO

    • Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY  • CYTOTOXIC API • EU GMP  • JGMP (Japan) • KGMP (Korea) • PIC/S
  • APIs

    Product APIs

    [Cytotoxic APIs] 

    Paclitaxel Produced by fermentation
    Paclitaxel Produced by a semi-synthetic process
    Docetaxel, anhydrous 
    Pemetrexed
    Bortezomib
    Cabazitaxel 


    Package: Up to 500g per request




    *If you need further information on our APIs,...
  • CDMO service

    Product CDMO service

    [Oncology CDMO Service for Cytotoxic Injectables]

    Product: Lyophilized Vials, Liquid Vials

    [Current Plant]

    - Certification: EU GMP, JGMP, KGMP, PIC/s

    - Production: Cytotoxic APIs, Cytotoxic Injectables (Liquid, Lyophilized vials) 

    - Capacity: 10~2...
  • FDFs

    Product FDFs

    Oncology products:
    Genexol PM (Paclitaxel)
    Nanoxel M (Docetaxel)
    Zolenic (Zoledronic acid)
    Injectables (Paclitaxel, Docetaxel, Oxaliplatin)
    Patch Products:
    Fentaderm (Fentanyl)
    Demencure (Rivastigmine)
    Nicostop (Nicotine)
    Rheumastop (Diclofenac Diethylammonium)
    Anigderm (Nitro...

Samyang Biopharmaceuticals Corp Resources (2)